Keyphrases
Cancer Patients
100%
Endometrial Cancer
100%
Adult Comorbidity Evaluation-27
100%
Confidence Interval
46%
Comorbidity
23%
Histologic
23%
Recurrence-free Survival
23%
Medical Comorbidity
23%
Adjuvant Therapy
15%
Risk of Death
15%
Univariable Analysis
15%
Endometrioid
15%
Treatment Type
15%
High Risk
7%
Working Diagnosis
7%
Diabetes
7%
Overall Survival
7%
Survival Data
7%
Median Overall Survival
7%
Obesity
7%
Stage Distribution
7%
Cancer Center
7%
Patient Demographics
7%
Prognostic Factors
7%
Tumor-specific
7%
Grade Distribution
7%
Cox Regression Analysis
7%
Patient Survival
7%
Marital Status
7%
Tumor Characteristics
7%
Hormone Therapy
7%
Age-stage
7%
Clear Cell
7%
Recurrence Risk
7%
Endometrial Carcinoma
7%
Neuroendocrine Tumor
7%
Radiation Chemotherapy
7%
Degree of Association
7%
Serous Cell
7%
Endometrial Clear Cell Carcinoma
7%
Serous
7%
Overall Survival Time
7%
Multivariable Cox Regression
7%
Treatment Information
7%
High-risk of Recurrence
7%
Aging Treatment
7%
Uterine Sarcoma
7%
Tumor Registry
7%
Primary Surgical Treatment
7%
Medicine and Dentistry
Uterine Cancer
100%
Comorbidity
100%
Recurrence Free Survival
15%
Neoplasm
10%
Overall Survival
10%
Recurrent Disease
10%
Endometrium Carcinoma
10%
Adjuvant Therapy
10%
Clear Cell
10%
Malignant Neoplasm
5%
Diabetes
5%
Proportional Hazards Model
5%
Cohort Analysis
5%
Specific Tumor
5%
Hormone Therapy
5%
Prognostic Factor
5%
Neuroendocrine Tumor
5%
Survival Time
5%
Marital Status
5%
Uterus Sarcoma
5%
Surgery
5%
Pharmacology, Toxicology and Pharmaceutical Science
Endometrium Cancer
100%
Comorbidity
100%
Neoplasm
15%
Recurrence Free Survival
15%
Overall Survival
10%
Recurrent Disease
10%
Endometrium Carcinoma
10%
Cohort Study
5%
Malignant Neoplasm
5%
Chemotherapy
5%
Endocrine Therapy
5%
Survival Time
5%
Neuroendocrine Tumor
5%
Uterus Sarcoma
5%